Results 41 to 50 of about 554,435 (240)

Male breast cancer

The Aging Male, 2011
Male breast cancer (MBC) is a rare disease. However, as global populace ages, there is a trend to MBC increasing. Although aetiology is still unclear, constitutional, environmental, hormonal (abnormalities in estrogen/androgen balance) and genetic (positive family history, Klinefelter syndrome, mutations in BRCA1 and specially BRCA2) risk factors are ...
Leonardo Oliveira, Reis, Fernando Gf, Dias, Marcos As, Castro, Ubirajara, Ferreira   +3 more
openaire   +2 more sources

The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer [PDF]

, 2015
BACKGROUND: A high percentage of stroma predicts poor survival in triple-negative breast cancers but is diminished in studies of unselected cases. We determined the prognostic significance of tumour-stroma ratio (TSR) in oestrogen receptor (ER)-positive
Downey CL, Hanby AM, Holliday DL, Jones JL, Jordan LB, Kulka, Janina, Pollock S, Rajan SS, Simpkins SA, Speirs V, Thygesen HH, White J   +11 more
core   +1 more source

MALE BREAST CANCER

International Journal of Clinical Practice, 1998
SUMMARY Male breast cancer is a rare disease, often with a late presentation and poor prognosis. The mainstay of treatment is modified radical mastectomy, with axillary node dissection to assess stage, prognosis and the need for adjuvant treatment. When matched for age, tumour size, grade and axillary nodal status, the prognosis is similar for males ...
A S, Jepson, I S, Fentiman
openaire   +2 more sources

Male breast cancer [PDF]

PONS - medicinski casopis, 2013
Male breast cancer is the rare disease. Risk factors for this disease are the hormone disbalance, BRCA 1 and BRCA 2 mutation and p53 mutation. In 40% cases it presents in III and IV stage. If the breast cancer is suspected, a 'triple assessment' approach (clinical examination, radiology imaging and histopathology verification) is the standard procedure.
Jovica Glisic, Jasmina Nedovic, Ljiljana Vasic, Biljana Markovic-Filipovic, Marija Protic, Marija Peulic   +5 more
openaire   +2 more sources

Male Breast Cancer in Portugal: A Descriptive Analysis of a 20-Year Cohort. [PDF]

Eur J Breast Health
Montenegro MA, Domingues TD, Garcia TM, Ferreira RQ, Furtado IT, Escaleira R, Verdasca FR, Simão DC, Fernandes L, Oliveira SD.   +9 more
europepmc   +3 more sources

Health considerations for transgender women and remaining unknowns : a narrative review [PDF]

, 2019
Transgender (trans) women (TW) were assigned male at birth but have a female gender identity or gender expression. The literature on management and health outcomes of TW has grown recently with more publication of research.
Defreyne, Justine, Iwamoto, Sean J, Motmans, Joz, Rothman, Micol S, T'Sjoen, Guy, Van de Bruaene, Laurens, Van Schuylenbergh, Judith   +6 more
core   +1 more source

The impact of known breast cancer polygenes on critical illness insurance [PDF]

, 2015
Genetic studies indicate that the inherited risk of breast cancer is mediated by the well-studied major genes BRCA1 and BRCA2, and a polygenic component, probably with many genes each making a small contribution. Recently, seven polygenes have been found
Adams, Craig, Donnelly, Catherine, Macdonald, Angus Smith   +2 more
core   +1 more source

Male breast cancer

Current Treatment Options in Oncology, 2003
Treatments for men with breast cancer are based largely on accepted regimens for women with the disease. Surgical treatment of the primary tumor should be a mastectomy. Lymph node assessment can be done by conventional axillary node dissection or, similar to selected women with small primary tumors, by sentinel node dissection.
Kayani, N, Khan, M N, Bhurgri, Y, Gill, S, Nasir, M I, Siddiqui, T   +5 more
openaire   +4 more sources

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting [PDF]

, 2008
: BACKGROUND: An increased risk of breast cancer for relatives of breast cancer patients has been demonstrated in many studies, and having a relative diagnosed with breast cancer at an early age is an indication for breast cancer screening.
A Lucassen, A Ziogras, AE Guttmacher, Caroline Seynaeve, Catharina E Jacobi, Cecile TM Brekelmans, Cees J Cornelisse, Christi J van Asperen, CJ Van Asperen, CJ Van Asperen, Collaborative Group on Hormonal Factors in Breast Cancer, D Ford, D Steinmann, D Thompson, DA Berry, DM Eccles, DM Eccles, EB Claus, EB Claus, Elly MM Krol-Warmerdam, FE Harrell Jr, G Parmigiani, Geertruida H de Bock, H Eerola, Jan GM Klijn, Jannet Blom, Johannes C van Houwelingen, JP Klein, KF Hoskins, KL Nathanson, O Visser, PD Pharoah, Peter Devilee, R Gershoni-Baruch, Rob AEM Tollenaar, RW Blamey, The Breast Cancer Linkage Consortium   +36 more
core   +8 more sources

Breast cancer: the first comparative evaluation of oncobiome composition between males and females

Biology of Sex Differences, 2023
Background Emerging evidence suggests that breast microbiota dysbiosis contributes to cancer initiation, progression, prognosis and treatment efficacy.
Elena Niccolai, Simone Baldi, Giulia Nannini, Francesca Gensini, Laura Papi, Vania Vezzosi, Simonetta Bianchi, Lorenzo Orzalesi, Matteo Ramazzotti, Amedeo Amedei   +9 more
doaj   +1 more source